Envista Investor Relations Material
Envista Holdings Corporation is an American company that owns a global group of more than 30 dental brands. These subsidiaries provide a comprehensive range of products and solutions for dentists and dental professionals. Their focus extends to diverse areas like implants, orthodontics, and digital imaging technologies. Envista's approach is to operate with a decentralized model, empowering individual brands to maintain their entrepreneurial spirit and brand identity while benefiting from the parent company’s resources. Envista is headquartered in Brea, California, and its shares are listed on the NYSE.
Spin-off from Danaher
Just like Fortive was created through a spin-off from Danaher, Envista Holdings was spun off in 2019 to enable a more focused and strategic approach in the dental sector. This move allowed Envista to concentrate exclusively on dental products and services, a distinct market with unique demands and opportunities and is something that Danaher does consistently.
By operating independently, Envista could pursue more targeted growth strategies, innovation, and customer engagement specific to its area of operations. The spin-off was part of Danaher's broader strategy to streamline its operations and create more value for shareholders by establishing standalone companies with dedicated resources and specialized market approaches.
Products and Services
Envista Holdings, through its subsidiaries, supplies the dental industry by offering a broad spectrum of products and services. Their subsidiaries specialize in things such as advanced dental implant technology, cutting-edge orthodontic products, consumables, and other equipment used in modern dentistry. It also offers technologies in digital imaging and diagnostics, which are crucial for modern dental care. Envista's subsidiaries also engage in developing CAD/CAM systems, used for complicated dental restorations where precision is incredibly important.
As previously mentioned, Envista Holdings employs a decentralized approach that allows its subsidiaries such as Nobel Biocare, Ormco, and Kerr to operate with a degree of autonomy. This model enables these companies to retain their unique brand identities and encourages innovation that is specifically tailored to their individual market segments.